Need professional-grade analysis? Visit stockanalysis.com
$3.55B
16.08
21,370
10.36%
Pharmaron Beijing Co., Ltd. (PHBBF) trades on United States in USD. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at $1.93.
Over the past year, PHBBF has traded between a low of $1.90 and a high of $1.93. The stock has gained 1.5% over this period.
Pharmaron Beijing Co., Ltd. has a market capitalization of $3.55B, with a price-to-earnings ratio of 16.08 and a dividend yield of 10.36%.
Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally. It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Production Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and Others. The company offers laboratory chemistry and biological science services, including small molecule chemical drugs, oligonucleotides, peptides, antibodies, antibody-drug conjugates (ADCs), and cell and gene therapy products; small molecule CDMO services, such as API process development and production, material science and preformulation, formulation development, and analytical development. It also provides clinical research services; macromolecular and cell and gene therapy services comprising drug discovery, development and production services, cell and gene therapy laboratory services, and gene therapy drug development and production services. In addition, the company is involved in the provision of technology development, technology transfer, technical consultation, technical services, and technical training; import and export of goods and technologies. Pharmaron Beijing Co., Ltd. was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.
Side-by-side comparison against top Healthcare peers.